Joer, el marcado está loco....
O vas a corto, a hacer metesacas, o crees en unos fundamentales y aguantas lo que haga falta...
CTIX, noticia tras noticia, y no levanta el vuelo ni harta de vino...
Cellceutix Meets With FDA for Phase 2 Clinical Trial of Kevetrin for Ovarian Cancer 2 febrero
Cellceutix Files Motion to Dismiss Complaint Filed by The Rosen Law Firm 12 febrero
Cellceutix Completes Clinical Trial of Kevetrin for Advanced Solid Tumors 16 febrero
Assay Results from Cellceutix Phase 1 Clinical Trial of Kevetrin for Cancer Show Increased p21 Expression in 67.5% of Evaluable Patients 22 febrero
http://cellceutix.us2.list-manage.com/track/click?u=9ed1a6b082ae8962468007971&id=3541f921bd&e=d9e5eae0f3 24 febrero
Cellceutix Submits Special Protocol Assessment Request to FDA for Phase 3 Clinical Trial of Brilacidin for ABSSSI 26 febrero
Cellceutix Completes Dosing in Phase 2 Trial of Prurisol for Chronic Psoriasis, Top-Line Data Anticipated in May 1 marzo